Literature DB >> 6270768

[Dysautonomia and behavioural disorders from periventricular metastasis (author's transl)].

J Barbizet, J D Degos, J Poirier, C Marsault, C Meyrignac.   

Abstract

In a patient presenting dysautonomia a severe orthostatic hypotension revealed the presence of a subependymal metastatic infiltration from a large cell anaplastic bronchial carcinoma. Clinical pharmacological studies were conducted. A paradoxical sinus bradycardia during orthostatism, and an absence of bradycardia after clonidine injection, were suggestive of a central origin of the dysautonomia. At post-mortem, metastatic infiltration involved the walls of the lateral ventricles, and the floor of the IIIrd and IVth ventricles, from where it invaded structures responsible for cardiovascular control. Correlations could be established between the results of the clinical pharmacological tests and the pathological findings. Also present were a) anterograde amnesia dating from the onset of the orthostatic hypotension, probably due to compression of the anterior pillars of the trigone by tumour invasion of the septum; b) behavioural disorders with absence of spontaneous movement and speech, indifference and docility, probably arising from destruction of the septum.

Entities:  

Mesh:

Year:  1981        PMID: 6270768

Source DB:  PubMed          Journal:  Rev Neurol (Paris)        ISSN: 0035-3787            Impact factor:   2.607


  3 in total

1.  The Phantom in our opera - or the hidden ways of the autonomic nervous system in cardiac patients.

Authors:  C van Tellingen
Journal:  Neth Heart J       Date:  2004-11       Impact factor: 2.380

2.  The Cushing response evoked by a fourth ventricular brainstem mass.

Authors:  Mark Quigg; Reza Sadjadi; Cynthia Brown
Journal:  Neurology       Date:  2014-07-25       Impact factor: 9.910

3.  Orthostatic hypotension associated with an epidermoid tumor of the IV ventricle.

Authors:  Juan Carlos Gómez-Esteban; Koldo Berganzo; Beatriz Tijero; Joseba Barcena; Juan J Zarranz
Journal:  J Neurol       Date:  2009-04-08       Impact factor: 4.849

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.